Colonoscopic Sucralfate Spray in Prevention of Delayed Polypectomy Bleeding
Bleeding
About this trial
This is an interventional prevention trial for Bleeding focused on measuring Polypectomy bleeding, Sulcralfate, Colonoscopic spray
Eligibility Criteria
Inclusion Criteria: who accept colonoscopy examinations with polyp size ≥ 0.5 cm for polyp excision Exclusion Criteria: patients with an allergy to sucralfate patients rejection
Sites / Locations
- Hsueh-Chien ChiangRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention group
Control group
After polypectomy with a suitable method, either cold snare polypectomy, hot snare polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection, we will monitor if immediate polypectomy bleeding occurs. If immediate bleeding occurs, we will apply standard endoscopic therapy by either local injection of diluted epinephrine, heater probe coagulation, and/or hemoclipping. If there is no immediate bleeding, we will apply prophylactic clipping in high-risk patients with polyp size ≥ 1cm. After then, we will spray 3g of sucralfate powder through colonoscopy precisely on the polypectomy wound in the intervention group.
After polypectomy with a suitable method, either cold snare polypectomy, hot snare polypectomy, endoscopic mucosal resection, or endoscopic submucosal dissection, we will monitor if immediate polypectomy bleeding occurs. If immediate bleeding occurs, we will apply standard endoscopic therapy by either local injection of diluted epinephrine, heater probe coagulation, and/or hemoclipping. If there is no immediate bleeding, we will apply prophylactic clipping in high-risk patients with polyp size ≥ 1cm.